Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

OGFR Activators

OGFR Activators are a distinct class of compounds that selectively enhance the functional activity of the Opioid Growth Factor Receptor (OGFR). These activators work through a myriad of signaling pathways to upregulate the receptor's activity, which plays a pivotal role in regulating cell proliferation and tissue organization. At the molecular level, these activators can influence the receptor conformation to promote its interaction with the native ligand, Opioid Growth Factor (OGF), also known as [Met^5]-enkephalin. This interaction typically inhibits cell division, suggesting that activators of OGFR may work by fine-tuning this response, rather than directly stimulating cell proliferation. Some activators may bind to allosteric sites on the receptor, thereby inducing a conformational change that increases the binding affinity or efficacy for the endogenous ligand. This mechanism ensures a sustained activation of OGFR without altering the levels of OGF itself. Additionally, certain small molecule activators might enhance the receptor's signaling by increasing its dimerization, a necessary step for effective signal transduction. This process can lead to the activation of downstream pathways that modulate cellular homeostasis and maintain tissue architecture.

Furthermore, OGFR Activators could also involve modulation of intracellular pathways that indirectly upregulate receptor function. For instance, by influencing the endocytic recycling of OGFR, these activators may maintain a steady-state receptor population on the cell surface, ready for OGF binding. This would potentiate the receptor's physiological signaling without affecting the ligand concentration. Some activators may even function by inhibiting phosphatases that typically dephosphorylate the receptor, thereby extending the duration of OGFR signaling once it has been activated by its ligand. It is also conceivable that certain activators enhance the expression of co-factors required for OGFR signaling, thus amplifying the pathway's response to OGF. By targeting these diverse, yet interconnected biochemical routes, OGFR Activators ensure the enhancement of OGFR's natural regulatory role in cellular processes. Each activator's mode of action is distinct, yet all converge on the common goal of enhancing OGFR signaling efficacy, thereby ensuring precision in controlling the biological outcomes modulated by this receptor.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Forskolin directly stimulates adenylyl cyclase, increasing intracellular cAMP levels. Elevated cAMP activates PKA, which can phosphorylate specific substrates potentially enhancing the functional activity of the OGFR by promoting cellular responses linked to OGFR signaling.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$162.00
$316.00
$559.00
$889.00
$1693.00
7
(1)

Sphingosine-1-phosphate acts on its G protein-coupled receptors, initiating an intracellular signaling cascade that can lead to the activation of the PI3K/AKT pathway, which in turn may enhance OGFR activity through cross-talk mechanisms.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$76.00
$265.00
80
(4)

Ionomycin is a calcium ionophore which raises intracellular calcium levels, activating calcium-dependent signaling pathways. These pathways can upregulate the activity of OGFR by promoting cellular processes that are calcium-dependent and OGFR-mediated.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 is a PI3K inhibitor that reduces signaling through the AKT pathway. The inhibition of this pathway can lead to a compensatory response enhancing OGFR activity as the cell seeks to maintain homeostasis.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

PMA is a PKC activator that modulates numerous signaling pathways, including those that can lead to the activation of OGFR by indirect mechanisms such as changes in cellular adhesion and migration associated with OGFR function.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$42.00
$72.00
$124.00
$238.00
$520.00
$1234.00
11
(1)

EGCG is a polyphenol that acts as an antioxidant and has been shown to influence multiple signaling pathways, including those involving kinases that may enhance OGFR activity by modulating kinase-driven signaling networks.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$54.00
$128.00
$199.00
$311.00
23
(1)

A23187 is a calcium ionophore, similar to ionomycin, and it also raises intracellular calcium levels. These elevated calcium levels can activate signaling pathways that indirectly enhance OGFR activity by promoting calcium-dependent cellular responses.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

Staurosporine is a broad-spectrum protein kinase inhibitor. By inhibiting certain kinases, it may lead to selective activation of pathways involving OGFR by alleviating inhibition on signaling processes where OGFR is a component.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

PD98059 is an inhibitor of MEK, which specifically inhibits the activation of MAPK/ERK. By dampening this pathway, there may be an indirect enhancement of OGFR activity due to the interconnectedness of cellular signaling networks.